337 related articles for article (PubMed ID: 20624918)
41. Cep164 is a mediator protein required for the maintenance of genomic stability through modulation of MDC1, RPA, and CHK1.
Sivasubramaniam S; Sun X; Pan YR; Wang S; Lee EY
Genes Dev; 2008 Mar; 22(5):587-600. PubMed ID: 18283122
[TBL] [Abstract][Full Text] [Related]
42. Simian virus 40 large T antigen disrupts genome integrity and activates a DNA damage response via Bub1 binding.
Hein J; Boichuk S; Wu J; Cheng Y; Freire R; Jat PS; Roberts TM; Gjoerup OV
J Virol; 2009 Jan; 83(1):117-27. PubMed ID: 18922873
[TBL] [Abstract][Full Text] [Related]
43. Mitotic entry upon Topo II catalytic inhibition is controlled by Chk1 and Plk1.
Arroyo M; Cañuelo A; Calahorra J; Hastert FD; Sánchez A; Clarke DJ; Marchal JA
FEBS J; 2020 Nov; 287(22):4933-4951. PubMed ID: 32144855
[TBL] [Abstract][Full Text] [Related]
44. Chk1- and claspin-dependent but ATR/ATM- and Rad17-independent DNA replication checkpoint response in HeLa cells.
Rodríguez-Bravo V; Guaita-Esteruelas S; Florensa R; Bachs O; Agell N
Cancer Res; 2006 Sep; 66(17):8672-9. PubMed ID: 16951182
[TBL] [Abstract][Full Text] [Related]
45. Polo-like kinase-1 in DNA damage response.
Hyun SY; Hwang HI; Jang YJ
BMB Rep; 2014 May; 47(5):249-55. PubMed ID: 24667170
[TBL] [Abstract][Full Text] [Related]
46. p53 Suppresses E2F1-dependent PLK1 expression upon DNA damage by forming p53-E2F1-DNA complex.
Zhou Z; Cao JX; Li SY; An GS; Ni JH; Jia HT
Exp Cell Res; 2013 Dec; 319(20):3104-15. PubMed ID: 24076372
[TBL] [Abstract][Full Text] [Related]
47. The Plk1 Polo box domain mediates a cell cycle and DNA damage regulated interaction with Chk2.
Tsvetkov LM; Tsekova RT; Xu X; Stern DF
Cell Cycle; 2005 Apr; 4(4):609-17. PubMed ID: 15876876
[TBL] [Abstract][Full Text] [Related]
48. Suppression of Vimentin Phosphorylation by the Avian Reovirus p17 through Inhibition of CDK1 and Plk1 Impacting the G2/M Phase of the Cell Cycle.
Chiu HC; Huang WR; Liao TL; Wu HY; Munir M; Shih WL; Liu HJ
PLoS One; 2016; 11(9):e0162356. PubMed ID: 27603133
[TBL] [Abstract][Full Text] [Related]
49. ATR-Chk2 signaling in p53 activation and DNA damage response during cisplatin-induced apoptosis.
Pabla N; Huang S; Mi QS; Daniel R; Dong Z
J Biol Chem; 2008 Mar; 283(10):6572-83. PubMed ID: 18162465
[TBL] [Abstract][Full Text] [Related]
50. ATR enforces the topoisomerase II-dependent G2 checkpoint through inhibition of Plk1 kinase.
Deming PB; Flores KG; Downes CS; Paules RS; Kaufmann WK
J Biol Chem; 2002 Sep; 277(39):36832-8. PubMed ID: 12147700
[TBL] [Abstract][Full Text] [Related]
51. ATR, Claspin and the Rad9-Rad1-Hus1 complex regulate Chk1 and Cdc25A in the absence of DNA damage.
Sørensen CS; Syljuåsen RG; Lukas J; Bartek J
Cell Cycle; 2004 Jul; 3(7):941-5. PubMed ID: 15190204
[TBL] [Abstract][Full Text] [Related]
52. Epstein-Barr virus lytic replication elicits ATM checkpoint signal transduction while providing an S-phase-like cellular environment.
Kudoh A; Fujita M; Zhang L; Shirata N; Daikoku T; Sugaya Y; Isomura H; Nishiyama Y; Tsurumi T
J Biol Chem; 2005 Mar; 280(9):8156-63. PubMed ID: 15611093
[TBL] [Abstract][Full Text] [Related]
53. Defective Mre11-dependent activation of Chk2 by ataxia telangiectasia mutated in colorectal carcinoma cells in response to replication-dependent DNA double strand breaks.
Takemura H; Rao VA; Sordet O; Furuta T; Miao ZH; Meng L; Zhang H; Pommier Y
J Biol Chem; 2006 Oct; 281(41):30814-23. PubMed ID: 16905549
[TBL] [Abstract][Full Text] [Related]
54. Checkpoint adaptation and recovery: back with Polo after the break.
van Vugt MA; Medema RH
Cell Cycle; 2004 Nov; 3(11):1383-6. PubMed ID: 15492511
[TBL] [Abstract][Full Text] [Related]
55. Ataxia telangiectasia mutated- and Rad3-related kinase drives both the early and the late DNA-damage response to the monofunctional antitumour alkylator S23906.
Soares DG; Battistella A; Rocca CJ; Matuo R; Henriques JA; Larsen AK; Escargueil AE
Biochem J; 2011 Jul; 437(1):63-73. PubMed ID: 21470188
[TBL] [Abstract][Full Text] [Related]
56. Role of ATM and the damage response mediator proteins 53BP1 and MDC1 in the maintenance of G(2)/M checkpoint arrest.
Shibata A; Barton O; Noon AT; Dahm K; Deckbar D; Goodarzi AA; Löbrich M; Jeggo PA
Mol Cell Biol; 2010 Jul; 30(13):3371-83. PubMed ID: 20421415
[TBL] [Abstract][Full Text] [Related]
57. Plk1-dependent phosphorylation regulates functions of DNA topoisomerase IIalpha in cell cycle progression.
Li H; Wang Y; Liu X
J Biol Chem; 2008 Mar; 283(10):6209-21. PubMed ID: 18171681
[TBL] [Abstract][Full Text] [Related]
58. PLK1 targets NOTCH1 during DNA damage and mitotic progression.
De Blasio C; Zonfrilli A; Franchitto M; Mariano G; Cialfi S; Verma N; Checquolo S; Bellavia D; Palermo R; Benelli D; Screpanti I; Talora C
J Biol Chem; 2019 Nov; 294(47):17941-17950. PubMed ID: 31597699
[TBL] [Abstract][Full Text] [Related]
59. An ATR- and Chk1-dependent S checkpoint inhibits replicon initiation following UVC-induced DNA damage.
Heffernan TP; Simpson DA; Frank AR; Heinloth AN; Paules RS; Cordeiro-Stone M; Kaufmann WK
Mol Cell Biol; 2002 Dec; 22(24):8552-61. PubMed ID: 12446774
[TBL] [Abstract][Full Text] [Related]
60. p53-dependent repression of polo-like kinase-1 (PLK1).
McKenzie L; King S; Marcar L; Nicol S; Dias SS; Schumm K; Robertson P; Bourdon JC; Perkins N; Fuller-Pace F; Meek DW
Cell Cycle; 2010 Oct; 9(20):4200-12. PubMed ID: 20962589
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
